Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients.

Dementia and geriatric cognitive disorders - 1 Jan 2006

Huey Edward D, Mirza Nadeem, Putnam Karen T, Soares Holly, Csako Gyorgy, Levy James A, Copenhaver Brittany, Cohen Robert M, Sunderland Trey

Abstract excerpt

BACKGROUND: Cerebrospinal fluid (CSF) measures of beta-amyloid(1-42 )and tau differ between patients with Alzheimer's Disease (AD) and elderly normal controls. The effect of time and APOE genotype on these biomarkers continues to be elucidated. METHODS: We assessed CSF beta-amyloid(1-42) and tau in 20 mild-to-moderate AD patients, 11 APOE epsilon4+ and 9 APOE epsilon4-, over a mean time of 3.8 years (range 1-11.1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Amyloid beta-Peptides

Share to Apolipoproteins E

Share to Biomarkers

Share to Neuropsychological Tests

Share to Peptide Fragments

Share to tau Proteins

Source

Identifiers

PMID: 16682793
DOI: 10.1159/000093261

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients.PMID 16682793Read ↗

Cerebrospinal beta-amyloid ((1-42)) in early Alzheimer's disease: association with apolipoprotein E genotype and cognitive decline.Semantic proximity Read ↗

CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity.Semantic proximity Read ↗

CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by age.Semantic proximity Read ↗

Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.Semantic proximity Read ↗

Cerebrospinal fluid markers for Alzheimer's disease over the lifespan: effects of age and the APOEε4 genotype.Semantic proximity Read ↗

Progression from MCI to AD: predictive value of CSF Aβ42 is modified by APOE genotype.Semantic proximity Read ↗

Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele epsilon 4 during 14 months follow-up.Semantic proximity Read ↗

Don't forget about tau: the effects of ApoE4 genotype on Alzheimer's disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment-data from the Dementia Competence Network.Semantic proximity Read ↗

Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype.Semantic proximity Read ↗

Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrationsSemantic proximity Read ↗

APOE ε4 carriership status enhances age-related changes in Alzheimer’s disease plasma biomarkers concentrationsSemantic proximity Read ↗

Longitudinal stability of CSF tau levels in Alzheimer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.